NEW YORK (GenomeWeb) – Meridian Bioscience said today that its fiscal third quarter revenues increased 2 percent year over year on strong sales in its Diagnostics unit.

For the third quarter ended June 30, Cincinnati, Ohio-based Meridian posted net revenues of $48.2 million compared to $47.2 million in the year ago quarter and falling shy of analysts' consensus estimate of $48.6 million. Excluding a negative foreign currency effect of approximately $1.5 million, revenues grew 5 percent, Meridian said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.